Kynam Capital Management »

Tyra Biosciences shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Tyra Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.1M 567k 15.99
2024-03-31 $8.4M 515k 16.40
2023-12-31 $4.7M 340k 13.85

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Tyra Biosciences

RA Capital Management
Boxer Capital
BVF
Canaan Partners XI
Nextech Invest
TCG Crossover Management
BlackRock
Vanguard Group
Perceptive Advisors
5AM Venture Management
Frazier Life Sciences Management
OrbiMed Advisors
Sio Capital Management
Kynam Capital Management
Geode Capital Management

View all funds holding Tyra Biosciences